About

Founded

2019

Headquarters

London, England, United Kingdom

Industry

Femtech

Company Description

There are 3.8 billion women in the world, let’s make their lives happier, healthier and longer. At Vira Health, we combine data, clinical best practice and behaviour change to solve the health and quality of life problems that affect billions of women worldwide. Our core product is Stella – an app that supports women through menopause with personalised treatment plans backed by the latest science and support from our trained experts.

Quick Links

Website Jobs

Funding

Total Raised

$14 million

Valuation

Undisclosed

Significant Investors

Octopus Ventures, Optum Ventures, LocalGlobe, MMC Ventures, Amino Collective

Company Traction

As of July 2023, Vira Health’s app, Stella, has rated 4.6/5 stars from 16 reviews on the Apple App Store and has 1,000+ downloads on the Google Play Store.

In November 2022, Vira Health acquired online HRT prescriber Alva for an undisclosed amount.

Leadership Team

Andrea Berchowitz: Co-Founder & CEO of Vira Health. Former Associate Partner at McKinsey & Company.

Rebecca Love: Co-Founder of Vira Health. Former University Lecturer, Health Studies at Bader International Study Centre.

Abraham Morse: VP of Clinical Affairs at Vira Health. Medical Director at EisnerAmper.

Robert O’Brien: Head of Engineering at Vira Health. Former Lead Software Engineer at Wealth Wizards.

Lisa Campana: Head of Design at Vira Health. Former Head of Design at Wunderman Thompson.

Press

Femtech Insider (November 8, 2022): Vira Health Acquires Fellow UK-based Menopause Startup Alva

TechCrunch (March 14, 2022): Vira Health gets $12M to dial up personalized menopause support

TechCrunch (July 28, 2021): Personalized menopause platform Vira Health raises £1.5M from LocalGlobe, MMC Ventures

Vira Health